Personal tools

MCL coexpression mm9:2079: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0003135!1.29e-20!15;UBERON:0003101!2.68e-19!16;UBERON:0000079!2.68e-19!16;UBERON:0004176!5.91e-18!17;UBERON:0009196!5.91e-18!17;UBERON:0009117!5.91e-18!17;UBERON:0000991!6.25e-17!18;UBERON:0005564!6.25e-17!18;UBERON:0003133!1.89e-16!24;UBERON:0000473!2.78e-16!14;UBERON:0005156!3.95e-15!26;UBERON:0000990!3.95e-15!26;UBERON:0003886!4.13e-10!38;UBERON:0002553!7.86e-10!39;UBERON:0001301!1.21e-09!3;UBERON:0006555!1.21e-09!3;UBERON:0005103!1.21e-09!3;UBERON:0000083!1.21e-09!3;UBERON:0009201!1.21e-09!3;UBERON:0004819!1.21e-09!3;UBERON:0006553!1.21e-09!3;UBERON:0003074!1.21e-09!3;UBERON:0003060!1.21e-09!3;UBERON:0004871!2.63e-09!3;UBERON:0002323!5.97e-08!37;UBERON:0004458!5.97e-08!37;UBERON:0000305!1.78e-07!1;UBERON:0000080!1.92e-07!4;UBERON:0005904!1.92e-07!4;UBERON:0006947!1.92e-07!4;UBERON:0002120!1.92e-07!4;UBERON:0004054!1.92e-07!4;UBERON:0004875!1.92e-07!4;UBERON:0004876!1.92e-07!4;UBERON:0005721!1.92e-07!4;UBERON:0005754!1.92e-07!4;UBERON:0007297!1.92e-07!4;UBERON:0003064!2.01e-07!14
|ontology_enrichment_uberon=UBERON:0003135!1.29e-20!15;UBERON:0003101!2.68e-19!16;UBERON:0000079!2.68e-19!16;UBERON:0004176!5.91e-18!17;UBERON:0009196!5.91e-18!17;UBERON:0009117!5.91e-18!17;UBERON:0000991!6.25e-17!18;UBERON:0005564!6.25e-17!18;UBERON:0003133!1.89e-16!24;UBERON:0000473!2.78e-16!14;UBERON:0005156!3.95e-15!26;UBERON:0000990!3.95e-15!26;UBERON:0003886!4.13e-10!38;UBERON:0002553!7.86e-10!39;UBERON:0001301!1.21e-09!3;UBERON:0006555!1.21e-09!3;UBERON:0005103!1.21e-09!3;UBERON:0000083!1.21e-09!3;UBERON:0009201!1.21e-09!3;UBERON:0004819!1.21e-09!3;UBERON:0006553!1.21e-09!3;UBERON:0003074!1.21e-09!3;UBERON:0003060!1.21e-09!3;UBERON:0004871!2.63e-09!3;UBERON:0002323!5.97e-08!37;UBERON:0004458!5.97e-08!37;UBERON:0000305!1.78e-07!1;UBERON:0000080!1.92e-07!4;UBERON:0005904!1.92e-07!4;UBERON:0006947!1.92e-07!4;UBERON:0002120!1.92e-07!4;UBERON:0004054!1.92e-07!4;UBERON:0004875!1.92e-07!4;UBERON:0004876!1.92e-07!4;UBERON:0005721!1.92e-07!4;UBERON:0005754!1.92e-07!4;UBERON:0007297!1.92e-07!4;UBERON:0003064!2.01e-07!14
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.128156,0.612053,0.688265,1.21364,0.704257,0.803568,0.96814,0.381467,0.489964,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.790816,0.711848,1.12823,0.471365,0.318879,0.503207,0.623685,0.460474,1.84911,0.434783,1.03515,0.478558,0.717547,0.185353,0.504971,0.0986756,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,0.205546,1.32691,0.323563,0.310084,0.318792,2.13544,1.08947,0.575233,0.37865,1.04072,0.884013,0.362446,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,2.77562,1.71135,1.14445,0.938512,0.264911,1.16494,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,1.65428,1.02384,0.456123,1.33244,0.970073,0.848526,2.13347,1.56496,1.09333,0.812403,1.13449,1.43038,1.2358,1.23918,0.680176,1.40022,0.839311,1.53196,0.195549,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,3.24316,1.35996,0.87653,1.28473,0.63863,0.650472,1.49167,1.20739,2.47662,0.630949,0.993294,0.830321,0.459159,0.788782,0.0824127
}}
}}

Revision as of 20:52, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:58377061..58377064,-p@chr13:58377061..58377064
-
Mm9::chrX:132619707..132619712,-p4@Nxf3
Mm9::chrX:132619735..132619743,-p3@Nxf3
Mm9::chrX:132619745..132619789,-p1@Nxf3


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
male reproductive organ1.29e-2015
male organism2.68e-1916
male reproductive system2.68e-1916
external genitalia5.91e-1817
indifferent external genitalia5.91e-1817
indifferent gonad5.91e-1817
gonad6.25e-1718
gonad primordium6.25e-1718
reproductive organ1.89e-1624
testis2.78e-1614
reproductive structure3.95e-1526
reproductive system3.95e-1526
body cavity precursor4.13e-1038
anatomical cavity7.86e-1039
epididymis1.21e-093
excretory tube1.21e-093
mesonephric epithelium1.21e-093
mesonephric tubule1.21e-093
nephric duct1.21e-093
kidney epithelium1.21e-093
renal duct1.21e-093
mesonephric duct1.21e-093
pronephric duct1.21e-093
somatic layer of lateral plate mesoderm2.63e-093
body cavity5.97e-0837
body cavity or lining5.97e-0837
amnion1.78e-071
mesonephros1.92e-074
duct of male reproductive system1.92e-074
male genital duct1.92e-074
pronephros1.92e-074
internal male genitalia1.92e-074
nephrogenic cord1.92e-074
urogenital ridge1.92e-074
pronephric mesoderm1.92e-074
rostral part of nephrogenic cord1.92e-074
presumptive pronephric mesoderm1.92e-074
intermediate mesoderm2.01e-0714


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}